Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography

NC Wunderlich, R Beigel, MJ Swaans, SY Ho… - JACC: Cardiovascular …, 2015 - jacc.org
Percutaneous left atrial appendage (LAA) exclusion is an evolving treatment to prevent
embolic events in patients with nonvalvular atrial fibrillation. In the past few years multiple …

MitraClip® therapy in patients with end‐stage systolic heart failure

O Franzen, J van der Heyden, S Baldus… - European journal of …, 2011 - Wiley Online Library
Aims To assess the feasibility, short‐term durability and clinical outcomes of MitraClip®
therapy for mitral regurgitation (MR) in patients with end‐stage heart failure and a severely …

[HTML][HTML] Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation

VJ Nijenhuis, J Brouwer, R Delewi… - … England Journal of …, 2020 - Mass Medical Soc
Background The roles of anticoagulation alone or with an antiplatelet agent after
transcatheter aortic-valve implantation (TAVI) have not been well studied. Methods We …

[HTML][HTML] Aspirin with or without clopidogrel after transcatheter aortic-valve implantation

J Brouwer, VJ Nijenhuis, R Delewi… - New England journal …, 2020 - Mass Medical Soc
Background The effect of single as compared with dual antiplatelet treatment on bleeding
and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients …

[HTML][HTML] Tricuspid regurgitation and the right ventricle in risk stratification and timing of intervention

BS Rana, S Robinson, R Francis, M Toshner… - Echo Research & …, 2019 - Springer
Tricuspid regurgitation natural history and treatment remains poorly understood. Right
ventricular function is a key factor in determining prognosis, timing for intervention and …

The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives

LIS Wintgens, M Maarse, MJ Swaans… - Expert review of …, 2020 - Taylor & Francis
Introduction Atrial fibrillation (AF) is associated with an increased risk of stroke. Stroke
prevention with oral anticoagulation (OAC) is recommended in AF patients at increased risk …

Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients

MJ Swaans, ALM Bakker, A Alipour, MC Post… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: The goal of this study was to compare survival between transcatheter mitral
valve (MV) repair using MitraClip system (Abbott Vascular, Santa Clara, California), MV …

Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study

MJ Swaans, MC Post, BJWM Rensing… - Journal of the …, 2012 - Am Heart Assoc
Background Drug‐refractory atrial fibrillation (AF) increasingly is being treated with catheter
ablation. However, the long‐term success rate, expressed as freedom from AF, is< 50 …

Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands

FS van den Brink, MJ Swaans… - … Journal–Quality of …, 2017 - academic.oup.com
Aims After the introduction of the European Society of Cardiology (ESC) guidelines on
prevention, diagnosis, and treatment of infective endocarditis (IE) in 2009, prophylaxis for …

Overview of mitral regurgitation in Europe: results from the European Registry of mitral regurgitation (EuMiClip)

JM Monteagudo Ruiz, M Galderisi… - European Heart …, 2018 - academic.oup.com
Aims To determine the prevalence of mitral regurgitation (MR) in a large cohort of
consecutive patients undergoing clinically indicated echocardiography and to examine the …